SEC Form 4 · accession 0001140361-18-035444
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Doug Alleavitch
Officer — VP, Quality
Period of report
Aug 1, 2018
Accepted (ET)
Aug 3, 2018 · 6:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 1, 2018 | M | 1,000 | $53.70 | A | 18,584 | D | |
| Common Stock | holding | — | — | — | 1,517 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $53.70 | Aug 1, 2018 | M | 1,000 | D | — | Apr 10, 2025 | Common Stock | 1,000 | 34,000 | D |
Explanation of responses
- F1Includes 9,000 restricted stock units.
- F225% of the shares subject to the option vest on the first anniversary measured from April 9, 2015 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.